Heat Shock Protein Inhibitor- MPT0B640 for COVID-19 Infection

NCT04526717 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study was determined not to initiate.

Conditions

Covid19

Interventions

DRUG: MPT0B640

Sponsor

J Ints Bio